Skip to main content
SpringerLink
Log in

Carbamazepine/denosumab/levetiracetam

Hypocalcaemia, vitamin D deficiency and secondary hyperparathyroidism: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zavratnik A, et al. Life threatening symptomat ichypocalcaemia triggered with denosumab in patient treated with chronic antiepileptic therapy. Osteoporosis International 30 (Suppl.): S379 (plus poster) abstr. P366, Jan 2019. Available from: URL: http://doi.org/10.1007/s00198-019-04993-w [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carbamazepine/denosumab/levetiracetam. Reactions Weekly 1838, 128 (2021). https://doi.org/10.1007/s40278-021-89447-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-89447-3

Search

Navigation